İn This Study, Patients Undergoing Bariatric Surgery Will be Divided Into Two Groups. The Control Group Will Receive Normal-flow, While the Study Group Will Receive Low-flow Inhalational Anesthesia. The Aim is to Compare the Incidence of Postop Atelectasis-between the Two Groups Using USG Evaluation

NCT ID: NCT07041567

Last Updated: 2025-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-20

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a clinical trial and its purpose is to evaluate the effect of low and normal flow anesthesia on atelectasis formation in patients undergoing bariatric surgery by ultrasonography.

In this study, lung ultrasounds and respiratory function tests will be performed on volunteers before and after surgery. These procedures are completely painless and safe.

No invasive procedure will be performed in the study; the methods used do not pose any additional risk other than existing treatment procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atelectasis Pulmonary Complications Ultrasonography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group (group N) - Standard flow anesthesia

İnhalational anesthesia

Group Type ACTIVE_COMPARATOR

Inhalational anesthesia

Intervention Type OTHER

In Group D, patients undergoing bariatric surgery will receive low-flow inhalational anesthesia (0.5-1 L/min) with sevoflurane. The aim is to evaluate whether the reduced fresh gas flow rate decreases the incidence of postoperative atelectasis, assessed via pulmonary ultrasonography.

In Group N, patients undergoing bariatric surgery will receive standard-flow inhalational anesthesia (2-4 L/min) with sevoflurane. This group serves as the comparator to evaluate the impact of flow rate on postoperative atelectasis incidence.

İntervention group (Group D) - Low Flow Anesthesia

İnhalational anesthesia

Group Type EXPERIMENTAL

Inhalational anesthesia

Intervention Type OTHER

In Group D, patients undergoing bariatric surgery will receive low-flow inhalational anesthesia (0.5-1 L/min) with sevoflurane. The aim is to evaluate whether the reduced fresh gas flow rate decreases the incidence of postoperative atelectasis, assessed via pulmonary ultrasonography.

In Group N, patients undergoing bariatric surgery will receive standard-flow inhalational anesthesia (2-4 L/min) with sevoflurane. This group serves as the comparator to evaluate the impact of flow rate on postoperative atelectasis incidence.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Inhalational anesthesia

In Group D, patients undergoing bariatric surgery will receive low-flow inhalational anesthesia (0.5-1 L/min) with sevoflurane. The aim is to evaluate whether the reduced fresh gas flow rate decreases the incidence of postoperative atelectasis, assessed via pulmonary ultrasonography.

In Group N, patients undergoing bariatric surgery will receive standard-flow inhalational anesthesia (2-4 L/min) with sevoflurane. This group serves as the comparator to evaluate the impact of flow rate on postoperative atelectasis incidence.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Normal flow inhalational anesthesia (Group N) Low flow inhalational anesthesia (Group D)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Will undergo Sleeve Gastrectomy surgery;
* 18-65 years old
* ASA III patients.

Exclusion Criteria

* Patients who do not give consent
* Patients with ASA 4 and above
* Those with serious respiratory comorbidities (interstitial lung disease, serious permanent lung diseases)
* Uncontrolled Hypertension, Diabetes Mellitus
* Under 18 and over 65 years of age
* Chronic renal failure, Liver failure
* CHF (EF\<30) will not be included in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dunyakhanim Farzaliyeva

RESIDENT DOCTOR

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BCAİA-AUD28

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Opioid-Free Versus Opioid-Based Anesthesia in Bariatric
NCT07105839 NOT_YET_RECRUITING PHASE4